Q3 - 2026 - Washington Trust Bancorp, Inc. Earnings Conference Call - WASHINGTON TRUST BANCORP INC

Financial Performance:

• Q3 2026 net income reached $19.4 million ($1.01/share), a $3.4 million increase sequentially.
• Pre-provisioned net revenue (PPNR) rose 20% QoQ and 26% YoY.
• Net interest income (NII) was $44.7 million (+7% QoQ, +15% YoY).
• Net interest margin (NIM) expanded to 2.84% (+11 bps QoQ, +44 bps YoY), boosted 2 bps by loan re-accrual interest.
• Non-interest income grew 9% QoQ to a new high; banking revenues fell 9% QoQ due to a softer mortgage pipeline and higher rates.
• Provision for credit losses was $1.8 million, driven by the restructuring of a $22.3M office loan ($18.5M returned to accrual, $3.8M charged off).
• Total loans grew 1% to increase in CRE portfolio; deposits rose 1% QoQ (+4% YoY); wholesale funding dropped 18% QoQ.
• Total equity declined $23 million due to AFS securities fair value adjustments and dividends; dividend maintained at $0.56/share.
• Effective tax rate was 20.4%; full-year 2026 guidance is 21.5%.

Guidance and Future Outlook:

• Q4 NIM guidance revised to a range of 2.85%–2.90%, reflecting the September Fed rate hike.
• Management estimates a 25 bps rate hike yields 1–2 bps in run-rate margin; asset sensitivity remains modest.
• Q4 expense guidance increased to approximately $41 million (including $750k charitable contribution), a $1.5 million increase over Q3 due to timing of new branch ramp-up, marketing, technology, and personnel investments.
• Loan growth expectations remain strong, targeting 10% annualized growth in the commercial book and ~5% annualized total portfolio growth.
• Q3 commercial growth was 2.3% (within 2–3% quarterly target range), with a $230M pipeline weighted toward commercial loans.
• No new branch openings planned for 2027, though expansion in Rhode Island continues with two new locations opening shortly.

Business Segments and Product Lines:

• CRE portfolio drove commercial loan growth, while C&I (commercial & industrial) and institutional lending faced headwinds in Q3 due to seasonality in the education sector.
• Wealth management revenues were flat QoQ (-1%) but up 7% YoY; asset-based revenues increased, offsetting seasonal tax servicing fee declines.
• Loan-related derivative income rose by $924,000; bank-owned life insurance income surged due to a $954,000 gain.
• $2B residential loan book expected to provide a 1–2 bps quarterly tailwind via reinvestment of cash flows from amortization and payoffs.

Market and Competitive Landscape:

• Market competition for high-quality CRE assets is intensifying, leading to narrowing spreads (170–180 bps for high-quality assets), which partially offsets repricing benefits.
• Strong deposit growth driven by institutional banking onboarding of operating accounts and a cross-sector approach to retail and commercial deposits.
• Loan-to-deposit ratio has fallen below 95%, well below historical averages, providing ample funding capacity.
• Commercial loan pipeline shows robust demand, particularly in C&I, with institutional activity expected to rebound in Q4 and Q1.

Risks and Challenges:

• Credit quality resolution involved a $22.3M office loan; a new $6M Class A loan moved to non-accrual due to valuation risk despite stable occupancy and sponsor commitment.
• A $6.6M lab space loan is in active discussions for an exit scenario.
• A $28M lab space loan remains in special mention; migration is expected pending tenant rent burn-off performance.
• Competitive pressure in deposit pricing and loan origination is noted as spreads tighten in a rising rate environment.
• Management cites high stock prices as a reason to defer share buybacks in favor of capital deployment for balance sheet growth.

Management Commentary and Tone:

• Tone was confident and pragmatic, emphasizing margin expansion, asset quality improvement, and strong capital adequacy.
• Management highlighted "prudent growth" and acknowledged the seasonal nature of institutional lending while projecting a strong pipeline for the end of the year.
• Clear stance on capital allocation: prioritizing balance sheet expansion and organic growth over share repurchases.

Analyst Questions and Answers:

• Margin & Rates: Analysts queried Q4/NIM outlook; management confirmed 2.85–2.90% Q4 guidance and explained asset sensitivity mechanics.
• Expense Run-rate: Management clarified Q4 expense increase includes branch ramp-up (Bristol/Plattville) and confirmed ~$750k–$800k annual run-rate per new branch.
• Loan Mix & Growth: Q&A covered the $2.1B SOFR/Prime loan book, residential reinvestment tailwinds, and the 10% commercial growth target.
• Credit Specifics: Detailed inquiries into the new non-performer ($6M Class A) and lab space assets; management cited valuation risk and lease-up phases as triggers.
• Capital & Buybacks: Analysts asked about capital ratios and buybacks; Ned Handy stated the price is too high to repurchase, preferring to fund loan growth.

Other Key Points:

• Two new Rhode Island branches are set to open in the coming months to support local market expansion.
• The Q3 credit provision included a one-time benefit from a loan returned to accrual status, which boosted NIM by 2 bps.
• Management reaffirmed that while the LDR is low, they plan to utilize wholesale funding if necessary to sustain loan growth targets.